Responses to Cytokines and Interferons that Depend upon JAKs and STATs

被引:83
|
作者
Stark, George R. [1 ]
Cheon, HyeonJoo [1 ]
Wang, Yuxin [1 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
来源
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY | 2018年 / 10卷 / 01期
关键词
GAIN-OF-FUNCTION; NF-KAPPA-B; SERINE PHOSPHORYLATION; UNPHOSPHORYLATED STAT3; SIGNAL TRANSDUCER; TYROSINE PHOSPHORYLATION; MITOCHONDRIAL STAT3; DNA-DAMAGE; IFN-GAMMA; TRANSCRIPTIONAL ACTIVITY;
D O I
10.1101/cshperspect.a028555
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many cytokines and all interferons activate members of a small family of kinases (the Janus kinases [JAKs]) and a slightly larger family of transcription factors (the signal transducers and activators of transcription [STATs]), which are essential components of pathways that induce the expression of specific sets of genes in susceptible cells. JAK-STAT pathways are required for many innate and acquired immune responses, and the activities of these pathways must be finely regulated to avoid major immune dysfunctions. Regulation is achieved through mechanisms that include the activation or induction of potent negative regulatory proteins, posttranslational modification of the STATs, and other modulatory effects that are cell-type specific. Mutations of JAKs and STATs can result in gains or losses of function and can predispose affected individuals to autoimmune disease, susceptibility to a variety of infections, or cancer. Here we review recent developments in the biochemistry, genetics, and biology of JAKs and STATs.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer
    O'Shea, John J.
    Holland, Steven M.
    Staudt, Louis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02): : 161 - 170
  • [32] Not just another meeting: the coming of age of JAKs and STATs
    Chen, EH
    Gadina, M
    Galon, J
    Chen, M
    O'Shea, JJ
    IMMUNOLOGY TODAY, 1998, 19 (08): : 338 - 341
  • [33] CYTOKINE SIGNAL-TRANSDUCTION - ROLE OF JAKS AND STATS
    OSHEA, JJ
    KAWAMURA, M
    CHEN, YQ
    HANSEN, E
    TORTOLIANI, J
    REIDY, M
    BACON, C
    JOHNSTON, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 488 - 488
  • [34] Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs
    Luo, C
    Laaja, P
    DRUG DISCOVERY TODAY, 2004, 9 (06) : 268 - 275
  • [35] JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia
    Venugopal, Sangeetha
    Bar-Natan, Michal
    Mascarenhas, John O.
    BLOOD REVIEWS, 2020, 40
  • [36] Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
    OShea, JJ
    IMMUNITY, 1997, 7 (01) : 1 - 11
  • [37] Interleukin-6 signalling: More than Jaks and STATs
    Eulenfeld, Rene
    Dittrich, Anna
    Khouri, Christina
    Mueller, Pia J.
    Muetze, Barbara
    Wolf, Alexandra
    Schaper, Fred
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2012, 91 (6-7) : 486 - 495
  • [38] Controlling nuclear JAKs and STATs for specific gene activation by IFNγ
    Noon-Song, Ezra N.
    Ahmed, Chulbul M.
    Dabelic, Rea
    Canton, Johnathan
    Johnson, Howard M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 410 (03) : 648 - 653
  • [39] JAKs-STATs信号传导途径的研究现状
    范贤明
    泸州医学院学报, 2003, (01) : 86 - 88
  • [40] Cytokines,STATs and Liver Disease
    Bin Gao~(1
    Cellular & Molecular Immunology, 2005, (02) : 92 - 100